West Plano Diabetes & Endcrn is categorized under Medical Centers in Plano, TX and active since 2011.
West Plano Diabetes & Endcrn was established in 2011, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Medical Centers business, which does work in the B2C market, and is classified as a Medical Centers, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Jeffrey H Perlman at the company’s single location by writing to 6214 West Parker Road, Plano, Texas TX 75093 or by phoning (972) 981-7812. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | West Plano Diabetes & Endcrn |
| Contact Person: | Jeffrey H Perlman |
| Address: | 6214 West Parker Road, Plano, Texas 75093 |
| Phone Number: | (972) 981-7812 |
| Website Address: | perlmansmd.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Medical Centers |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
West Plano Diabetes & Endcrn was started in 2011 to provide professional Medical Centers under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Jeffrey H Perlman for inquiries that concern West Plano Diabetes & Endcrn by calling the company number (972) 981-7812, as your correspondence is most welcome. Additionally, the physical location of the single location of West Plano Diabetes & Endcrn can be found at the coordinates 33.04513,-96.83741 as well as the street address 6214 West Parker Road in Plano, Texas 75093.
For its online presence, you may visit West Plano Diabetes & Endcrn’s website at perlmansmd.com and engage with its social media outlets through on Twitter and on Facebook.